CA2012013A1 - Antibiotique bmy-41339 antimoral - Google Patents

Antibiotique bmy-41339 antimoral

Info

Publication number
CA2012013A1
CA2012013A1 CA2012013A CA2012013A CA2012013A1 CA 2012013 A1 CA2012013 A1 CA 2012013A1 CA 2012013 A CA2012013 A CA 2012013A CA 2012013 A CA2012013 A CA 2012013A CA 2012013 A1 CA2012013 A1 CA 2012013A1
Authority
CA
Canada
Prior art keywords
bmy
antitumor antibiotic
antibiotic bmy
expetimental
tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2012013A
Other languages
English (en)
Other versions
CA2012013C (fr
Inventor
Jerzy Golik
Patrick K. Clark
John M. Roach
John A. Beutler
John T. Ross
Gary M. Muschik
William B. Lebherz, Iii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
US Department of Health and Human Services
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2012013A1 publication Critical patent/CA2012013A1/fr
Application granted granted Critical
Publication of CA2012013C publication Critical patent/CA2012013C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03—Actinomadura

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002012013A 1989-03-15 1990-03-13 Antibiotique bmy-41339 antimoral Expired - Fee Related CA2012013C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US323,648 1989-03-15
US07/323,648 US5028536A (en) 1989-03-15 1989-03-15 Antitumor antibiotic BMY-41339

Publications (2)

Publication Number Publication Date
CA2012013A1 true CA2012013A1 (fr) 1990-09-15
CA2012013C CA2012013C (fr) 1995-08-22

Family

ID=23260110

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002012013A Expired - Fee Related CA2012013C (fr) 1989-03-15 1990-03-13 Antibiotique bmy-41339 antimoral

Country Status (4)

Country Link
US (1) US5028536A (fr)
EP (1) EP0387860A3 (fr)
JP (1) JPH0672150B2 (fr)
CA (1) CA2012013C (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA21697A1 (fr) * 1988-12-19 1990-07-01 Dow Agrosciences Llc Composes de macrolides.
US5227295A (en) * 1991-11-08 1993-07-13 Dowelanco Process for isolating A83543 and its components
US5591606A (en) * 1992-11-06 1997-01-07 Dowelanco Process for the production of A83543 compounds with Saccharopolyspora spinosa
BR9406587A (pt) * 1993-03-12 1996-01-02 Dowelanco Novos compostos a83543 e processo para a produção dos mesmos
US6001981A (en) * 1996-06-13 1999-12-14 Dow Agrosciences Llc Synthetic modification of Spinosyn compounds
US5781032A (en) * 1996-09-09 1998-07-14 International Business Machines Corporation Programmable inverter circuit used in a programmable logic cell

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH663155A5 (en) * 1983-05-16 1987-11-30 Bristol Myers Co Antitumour antibiotics
US4675187A (en) * 1983-05-16 1987-06-23 Bristol-Myers Company BBM-1675, a new antibiotic complex
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
US4594248A (en) * 1985-03-15 1986-06-10 Warner-Lambert Company CL-1577-B4 compound, its production and use
IL79519A0 (en) * 1985-08-27 1986-10-31 Bristol Myers Co Bbm-1675c and d antitumor antibiotics

Also Published As

Publication number Publication date
CA2012013C (fr) 1995-08-22
JPH0672150B2 (ja) 1994-09-14
US5028536A (en) 1991-07-02
EP0387860A2 (fr) 1990-09-19
JPH03141290A (ja) 1991-06-17
EP0387860A3 (fr) 1991-10-16

Similar Documents

Publication Publication Date Title
EP0388962A3 (fr) BMY 41950 antitumeur, antibiotique
IE44818L (en) Anthracycline antibiotics.
SE8502135D0 (sv) 4'-deschlororebeccamycin and process for its preparation
IE791948L (en) A-21978 peptide antibiotics
CA2016101A1 (fr) Amelioration de la croissance de semis de coniferes
CA2012013A1 (fr) Antibiotique bmy-41339 antimoral
IE782078L (en) Deoxynarasin antibiotics
EP0334632A3 (fr) Antibiotique
MY100478A (en) Antitumor antibiotic compound
CA2004197A1 (fr) Ab-021 antibiotique et procede de production
EP0350623A3 (fr) Antibiotique antitumoral BU3420T
EP0161849A3 (fr) Composés antibiotiques-antitumoraux CL-1724, les compositions pharmaceutiques les contenant et un micro-organisme producteur desdits composés
AU2971189A (en) Acidic polycyclic ether antibiotic having anticoccidial and growth promotant activity
IE841200L (en) B.b.m. - 1675 antibiotics
IL94870A0 (en) Acaricidal compositions containing bacterial fermentation broth and their preparation
IE55800B1 (en) Antitumor antibiotic
EP0257276A3 (fr) Procédé de préparation de l'antibiotique LL-42067alpha
CA2038667A1 (fr) Procede de preparation de derives de teicoplanine de mannosyle et d'aglycone de teicoplanine de mannosyle
CA2027629A1 (fr) Antibiotiques a base de glycopeptides
GB2137204B (en) Improvements in or relating to macrolideantibiotics
IE890724L (en) Bu-3862t antitumor antibiotic
GR3006381T3 (fr)
EP0299707A3 (fr) Antibiotiques glycopeptidiques
AU7742491A (en) Synthetic piperidinediones with cytostatic activity
CA2017276A1 (fr) Conagenine, antibiotique antitumoral ou carcinostatique, production et utilisation

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed